Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eleutherococcus fluid extract is a traditional herbal medicine produced by OJSC Dalkhimpharm, derived from the roots and rhizomes of *Eleutherococcus senticosus* (Siberian ginseng). It is prepared as a 1:1 fluid extract using 40% ethanol as the solvent. Classified as an adaptogen and tonic agent (ATC code A13A), the extract contains a complex mixture of active phytochemicals, most notably eleutherosides (glycosides A-M), phenolic compounds, and polysaccharides. The medicine is primarily indicated for the treatment of asthenia, fatigue, and decreased physical or mental performance. It works by enhancing the body's non-specific resistance to various stressors and adverse environmental factors, a property characteristic of adaptogenic substances. This product has been industrially produced in Russia since 1964 and remains a staple of the regional pharmacopeia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eleutherococcus fluid extract.